JPMorgan Chase & Co. Sells 7,313 Shares of Mettler-Toledo International Inc. (MTD)


JPMorgan Chase & Co. reduced its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 13.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 46,280 shares of the medical instruments supplier’s stock after selling 7,313 shares during the period. JPMorgan Chase & Co. owned about 0.18% of Mettler-Toledo International worth $26,613,000 at the end of the most recent reporting period.


Other hedge funds have also recently made changes to their positions in the company. Signaturefd LLC bought a new position in Mettler-Toledo International during the 1st quarter valued at about $111,000. Alps Advisors Inc. bought a new position in Mettler-Toledo International during the 1st quarter valued at about $202,000. Campbell & CO Investment Adviser LLC bought a new position in Mettler-Toledo International during the 1st quarter valued at about $251,000. Canandaigua National Bank & Trust Co. bought a new position in Mettler-Toledo International during the 1st quarter valued at about $397,000. Finally, We Are One Seven LLC bought a new position in Mettler-Toledo International during the 4th quarter valued at about $427,000. 92.32% of the stock is owned by hedge funds and other institutional investors.


Get Mettler-Toledo International alerts:

In other news, insider William P. Donnelly sold 5,000 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, May 11th. The shares were sold at an average price of $563.38, for a total transaction of $2,816,900.00. Following the completion of the sale, the insider now owns 4,000 shares in the company, valued at approximately $2,253,520. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider William P. Donnelly sold 4,000 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, May 14th. The stock was sold at an average price of $567.85, for a total transaction of $2,271,400.00. Following the sale, the insider now owns 5,000 shares of the company’s stock, valued at approximately $2,839,250. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,934 shares of company stock valued at $10,795,962. Insiders own 4.80% of the company’s stock.


Shares of NYSE MTD opened at $595.14 on Wednesday. Mettler-Toledo International Inc. has a 1-year low of $540.24 and a 1-year high of $697.26. The stock has a market capitalization of $15.04 billion, a price-to-earnings ratio of 33.87, a P/E/G ratio of 2.26 and a beta of 1.19. The company has a quick ratio of 1.02, a current ratio of 1.46 and a debt-to-equity ratio of 1.75.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 3rd. The medical instruments supplier reported $3.74 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.73 by $0.01. Mettler-Toledo International had a net margin of 13.50% and a return on equity of 90.70%. The company had revenue of $660.82 million during the quarter, compared to the consensus estimate of $651.87 million. During the same period in the previous year, the firm posted $3.34 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. equities research analysts anticipate that Mettler-Toledo International Inc. will post 20.25 earnings per share for the current year.


Several brokerages recently issued reports on MTD. Deutsche Bank lifted their price target on shares of Mettler-Toledo International from $600.00 to $630.00 and gave the company a “hold” rating in a report on Thursday, March 1st. Morgan Stanley cut their price target on shares of Mettler-Toledo International from $595.00 to $568.00 and set an “equal weight” rating for the company in a report on Wednesday, April 11th. Zacks Investment Research raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $640.00 price target for the company in a report on Wednesday, April 11th. Bank of America cut their price target on shares of Mettler-Toledo International from $710.00 to $640.00 and set a “buy” rating for the company in a report on Friday, May 4th. Finally, Goldman Sachs Group downgraded shares of Mettler-Toledo International from a “buy” rating to a “neutral” rating in a report on Monday, April 9th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Mettler-Toledo International currently has an average rating of “Hold” and an average price target of $632.00.


Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)